Skip to content

Avista AVA Other Regulatory Assets And Liabilities

Other Regulatory Assets And Liabilities at other companies

OGS
ONE GASOGS
$69.96M-5.3%
Southern Company logo
Southern CompanySO
$706M
Spire logo
SpireSR
$3.64B+12.0%
AWR
American States WaterAWR
-$11.8M-933%
New Jersey Resources logo
New Jersey ResourcesNJR
$31.95M-8.3%
CHE
ChemedCHE
$4.69M+10.5%

Other financials

Income statement

See full
Revenue$570.0M-7.6%
Operating income$134.0M+7.2%
Net income$92.0M+16.5%
EPS (diluted)$1.11+13.3%

Balance sheet

See full
Cash & equivalents$18.0M+5.9%
Total debt$416.0M+30.8%
Total equity$2.8B+4.8%
Total assets$8.4B+5.5%

Cash flow

See full
Operating cash flow$179.0M-2.7%
CapEx$150.0M+45.6%
Free cash flow$29.0M-64.2%

Valuation

See full
Market cap$3.36B-1.8%

Profitability

See full
Operating margin18.9%+1.9pp
Net margin10.7%+1.1pp
FCF margin-8%

Returns & leverage

See full
Return on equity7.6%+0.4pp
Debt / equity0.1×0.0×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Avista in its filing.

Tagged under the XBRL concept ava:OtherRegulatoryAssetsAndLiabilities.

The official record: Avista’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avista's other regulatory assets and liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avista's other regulatory assets and liabilities?
Avista (AVA) reported other regulatory assets and liabilities of -$3M in Q1 2026.
How has Avista's other regulatory assets and liabilities changed year-over-year?
Avista's other regulatory assets and liabilities increased by 86.4% year-over-year, from -$22M to -$3M.
What is the long-term trend for Avista's other regulatory assets and liabilities?
Over 3 years (2021 to 2025), Avista's other regulatory assets and liabilities has grown at a 95.1% compound annual growth rate (CAGR), from -$4.45M to -$33M.
What does other regulatory assets and liabilities mean?
Captures the net change in regulatory assets and liabilities that do not fall under specific deferral categories but are subject to regulatory accounting treatment. These items represent costs or credits that regulators have authorized for future recovery or refund. Monitoring this helps investors understand the long-term impact of regulatory decisions on the company's financial position.